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Introduction
Fanconi anemia (FA) is a rare genetic disease characterized by 
chromosomal instability and impaired DNA damage repair 
(Alter 2014). Patients show progressive pancytopenia and are at 
a high risk of developing malignant solid tumors, particularly 
head and neck squamous cell carcinomas (HNSCC) (Alter 
2014). FA patients develop HNSCC much earlier and at a higher 
frequency than the general population—700 times more 
likely—even in the absence of known risks for cancer, such as 
tobacco and alcohol (Romick-Rosendale et al. 2013; Alter 
2014). Cancer rates increase significantly after hematopoietic 
stem cell transplantation (HSCT), which is the main treatment 
to restore normal hematopoiesis (Alter 2014), and among 
patients with a history of graft-versus-host disease (GVHD).
The causes of the high incidence of oral squamous cell car-
cinoma (OSCC) in FA patients remain unclear. Human papil-
lomavirus (HPV) has been identified as an etiological agent for 
oropharyngeal cancer (van Monsjou et al. 2013). However, the 
contribution of HPV to oral carcinogenesis in FA patients is 
controversial and published reports seem contradictory (Alter 
et al. 2013).
There is increasing evidence for an etiological role of bac-
teria in cancer development. Elevated levels of certain species/
genera such as Helicobacter pylori, Neisseria and Veilonella, 
and Fusobacterium nucleatum have been associated with 
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Abstract
Fanconi anemia (FA) is a rare genetic disease characterized by chromosomal instability and impaired DNA damage repair. FA patients 
develop oral squamous cell carcinoma (OSCC) earlier and more frequently than the general population, especially after hematopoietic 
stem cell transplantation (HSCT). Although evidence of an etiological role of the local microbiome and carcinogenesis has been mounting, 
no information exists regarding the oral microbiome of FA patients. The aim of this study was to explore the salivary microbiome of 61 
FA patients regarding their oral health status and OSCC risk factors. After answering a questionnaire and receiving clinical examination, 
saliva samples were collected and analyzed using 16S rRNA sequencing of the V3-V4 hypervariable region. The microbial profiles 
associated with medical and clinical parameters were analyzed using general linear models. Patients were young (mean age, 22 y) and most 
had received HSCT (n = 53). The most abundant phyla were Firmicutes [mean relative abundance (SD), 42.1% (10.1%)] and Bacteroidetes 
[(25.4% (11.4%)]. A history of graft-versus-host disease (GVHD) (n = 27) was associated with higher proportions of Firmicutes (43.8% 
× 38.5%, P = 0.05). High levels of gingival bleeding were associated with the genera Prevotella (22.25% × 20%), Streptococcus (19.83% × 
17.61%), Porphyromonas (3.63% × 1.42%, P = 0.03), Treponema (1.02% × 0.28%, P = 0.009), Parvimonas (0.28% × 0.07%, P = 0.02) and 
Dialister (0.27% × 0.10%, P = 0.04). Finally, participants transplanted over 11 y ago showed the highest levels of Streptococcus (18.4%), 
Haemophilus (12.7%) and Neisseria (6.8%). In conclusion, FA patients that showed poor oral hygiene harbored higher proportions of the 
genera of bacteria compatible with gingival disease. Specific microbial differences were associated with a history of oral GVHD and a 
history of oral mucositis.
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gastric adenocarcinoma, esophageal carcinoma and colorectal 
carcinoma, respectively (Correa and Houghton 2007; Mima et 
al. 2015; Pilato et al. 2016). Mager et al. (2005) showed that 
certain oral species had diagnostic properties in identifying 
OSCC patients, even after controlling for smoking and alcohol 
consumption. Although association does not imply causation, 
several mechanisms have been postulated by which the local 
microbiome can contribute to carcinogenesis, including epi-
genetic DNA modifications, direct DNA damage, inflamma-
tion and synthesis of carcinogenic metabolites (Schwabe and 
Jobin 2013). Collectively, these studies provide a compelling 
conceptual framework to explore the associations between the 
oral microbiome and carcinogenesis in FA.
Due to the complexity of the oral microbiome, which 
encompasses more than 700 bacterial species, 35% of which 
have not yet been cultivated (Dewhirst et al. 2010), the com-
prehensive analysis afforded by sequencing of the 16S rRNA 
gene is rather appealing. Its open-ended character allows for 
the discovery of new taxa potentially related to disease, and its 
culture-independent nature does not exclude species and phy-
lotypes that are difficult to grow or currently uncultivated but 
that might have a role in disease initiation. The most recent 
studies of the association between the oral microbiome and 
OSCC have used 454 pyrosequencing (Schmidt et al 2014; 
Guerrero-Preston et al. 2016).  However, this form of sequenc-
ing has recently been outperformed by MiSeq Illumina 
sequencing (Caporaso et al. 2012), which has a lower error rate 
and generates over 10 times more reads (Nelson et al. 2014) 
and has thus become the leading sequencing platform for 
human microbiome studies (Amarasekara et al. 2015).
The growing evidence for the role of infection and inflamma-
tion in carcinogenesis in the general population has made it 
rather compelling to evaluate the microbial challenges sustained 
by a population genetically predisposed to DNA damage and 
cancer development, such as the FA population. Despite their 
extreme risk for OSCC, there are no comprehensive microbio-
logical assessments of the FA oral cavity. Therefore, the aim of 
this study was to explore the microbial salivary profiles of FA 
patients considering their oral health status and OSCC risk fac-
tors using 16S rRNA MiSeq Illumina sequencing.
Materials and Methods
Study Population
This study was approved by the Brazilian National Research 
Ethics Committee (Approval number 1.219.800) and the 
Office of Human Research Ethics from North Carolina at 
Chapel Hill University (Study #15-2381). The methodology is 
in accord with Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) guidelines. All patients 
who participated in the IV Brazilian FA Family Meeting 
(Curitiba, Brazil) were invited to participate in this study.
Increasing age, history of HSCT, oral GVHD and oral 
mucositis, and the presence of potentially malignant oral 
lesions (PMOL) are proposed risk factors for OSSC develop-
ment in FA (Bonfim et al. 2016). Thus, the microbial profile of 
each parameter was analyzed as a composite, as follows: high 
risk, HSCT for more than 5 y before the current examination or 
≥18 y and presenting with PMOL; moderate risk, <18 y and 
presenting with PMOL or >18 y without PMOL; low risk, <18 
y without PMOL and HSCT within the last 5 y.
After signing an informed consent, participants responded 
to a questionnaire including socio-demographic and behavioral 
information and modification of the instrument validated by 
Eke et al. (2013) for self-reporting periodontitis. Blood test 
results, time of transplantation, GVHD history, and oral muco-
sitis were obtained from clinical charts.
Saliva Collection and Clinical Monitoring
Patients were asked to refrain from eating or tooth brushing for 
1 h before sample collection. For each patient, non-stimulated 
saliva was collected into a sterile Falcon tube on ice. The tube 
was vortexed and 500 µL aliquots of saliva were frozen in ster-
ile cryogenic tubes (−80 ºC) and stored until analysis.
Clinical Measurements
All measurements were performed by one trained dentist using 
an artificial light, gauze, and a mouth mirror. The oral health 
status was determined by the Visual Plaque Index (VPI), using 
the dichotomous plaque score of 6 sites for each natural tooth 
selected (16, 11, 26, 36, 31, and 46) (Ainamo and Bay 1975). 
The number of decayed, missing, and filled teeth (DMFT) was 
determined according WHO guidelines, and full mouth Gingival 
Bleeding Index (GBI) was determined using dental floss (Carter 
and Barnes 1974). The dentist then performed a clinical exami-
nation for the presence of leukoplakia, erythroplakia, erythro-
leukoplakia and oral GVHD lesions (collectively classified as 
PMOL to distinguish them from benign oral conditions). 
PMOLs were classified per the WHO and NIH criteria for 
leukoplakia and GVHD, respectively (Warnakulasuriya et al. 
2007). The history of oral mucositis was stratified into levels I 
(Level 0 and 1), II (Level 2) and III (3 and 4), according to 
increasing severity.
DNA Extraction, Library Preparation  
and 16S rRNA Sequencing
DNA extraction from samples was performed using the 
MasterPure DNA Purification kit (Epicentre, Illumina) per the 
manufacturer’s recommendations. We included an overnight 
incubation with lysozyme at 37 °C to assure isolation of DNA 
from Gram-positive bacteria. DNA quality and quantity were 
assessed (260/280 and 260/230 ratios, NanoDrop 1000 
Spectrophotometer; Thermo Fisher Scientific). A modified proto-
col was used for 16S rRNA amplicon sequencing library prepara-
tion (Caporaso et al. 2011). The variable region V3–V4 of the 
16S rRNA gene was PCR amplified using barcoded 341F and 
806R 16S primers (Caporaso et al. 2012). The amplicon size was 
approximately 460 bp. PCR products were purified (AMPure 
beads Beckman Coulter) and quantified (Quant-iT™ PicoGreen® 
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dsDNA Reagent, Molecular Probes). Equimolar amounts of each 
library were pooled, gel-purified, analyzed and quantified (2100 
Bioanalyzer, DNA High Sensitivity chip; Agilent Technologies). 
The library mixture (6 picomolars spiked with 30% PhiX) were 
run on a MiSeq instrument (Illumina). Automated cluster genera-
tion and paired–end sequencing using a 500-cycle reagent kit 
were performed per the manufacturer’s instructions. The entire 
protocol is described in the Supplemental Appendix.
Data Analysis
After removal of chimeric sequences and sequences that failed 
quality control, sequencing reads were evaluated using the 
QIIME analysis pipeline (Quantitative Insights Into Microbial 
Ecology, qiime.org, version 1.8). Reads were grouped into 
Operational Taxonomic Units (OTUs) using UCLUST and the 
bacterial taxonomy was determined using Greengenes. After 
taxonomic assignment, OTUs were combined with sample 
metadata. The relative abundance of the taxa present in each 
sample was computed at the phylum and genus levels. The 
microbial profile variables of interest (i.e., potentially associ-
ated with increased risk to OSCC), including age, time since 
bone marrow transplantation, history of GVHD and oral health 
status, were evaluated using general linear models, correlation 
analyses and t and x2 tests. The false discovery rate (FDR) was 
used to adjust for multiple comparisons.
Results
Sociodemographic, Behavioral and Oral Health 
Characteristics of the Study Population
The study population was composed of 61 FA patients, most of 
whom were young [mean (SD), 22 y (7.6 y)] and male (57.4%). 
Clinical examination indicated that the mean VPI and GBI were 
31.3% (27.1%) and 34.2% (25.9%), respectively, and that the 
mean DMFT was 5.3 (5.6). PMOL was identified in 38 partici-
pants (62.3%), primarily in the palate (n = 21), tongue (n = 19) 
and retrocomissural mucosa (n = 19) (Appendix Table 3); leuko-
plakia was identified in 81.5% of these participants with PMOL 
(Appendix Table 4). PMOLSs were more frequent in  older 
patients (PMOL presence x absence; 24 years old x 19 years old, 
P = 0.007) and in participants with longer time since HSCT (12 
years x 8 years, P = 0.025.
Prevalence of Potential Risk Factors for OSCC in FA
On average, the study participants had been diagnosed with FA 
for 13 y (SD, 6 y; range, 2 to 28 y), and 86.9% of these partici-
pants had received HSCT. Among these, the mean time since 
HSCT was 11 y (6 y; 1 to 27 y). Several patients had experi-
enced systemic (56.6%) or oral (50.9%) GVHD or mucositis 
(92.4%) post-HSCT. Further, a few participants described 
themselves as current (n = 1) or former (n = 6) smokers, or cur-
rent (n = 11) or former (n = 2) alcohol drinkers. Regarding the 
OSSC risk-based grouping, participants in the high-risk cate-
gory reported more gingival bleeding (32.8% v. 4.9% in the 
medium- to low-risk category) and loose bone around their 
teeth (18% v. 3.3%); although, those differences did not reach 
statistical significance. In addition, the 2 groups had similar 
scores for DMFT, VPI and GBI (Table).
Overall Sequencing Data and Microbial Profile
All samples were sequenced in the same run, which generated 
a total of 1,208,196 reads, and yielded, on average, 20,137 
(24,731) reads (median, 17,184), and a range of 3,298 to 
203,958 reads (all but one sample were in the 3,298 to 30,393 
range). One sample was excluded from the analysis due to 
low read numbers. Sequencing revealed 13 different phyla, 
where Firmicutes [42.16% (10.17%)] and Bacteroidetes 
[25.7% (11.16%)] predominated, and 77 genera were present, 
led by Prevotella [20.61% (11.28%)], Veillonella [(18.28% 
(9.56%)] and Streptococcus [18.06% (9.41%)]. (Appendix 
Tables 1 and 2).
Microbial Profiles Associated with Oral Health 
Parameters and Measurements
DMFT, VPI and GBI were dichotomized according to the 
upper quartile of their distribution. Participants with a DMFT 
greater than or equal to 8 had higher levels of Streptococcus 
(23.48% v. 16.26%; P = 0.007) and Treponema (0.99% v. 
0.32%, P = 0.01) and those with DMFT < 8 had higher propor-
tions of Prevotella (21.26% v. 17.83%), Veillonella (18.42% v. 
17.51%) and Actinomyces (2.83% v. 1.61%, P = 0.04) 
(Appendix Fig. 1). Participants at 75th percentile of the VPI 
distribution harbored greater levels of Veillonella (19.26% v. 
17.80%, P = 0.05), Streptococcus (18.91% v. 17.88%), 
Porphyromonas (2.86% v. 1.59%), Selenomonas (1.36% v. 
0.53%) and Treponema (0.96% v. 0.33%) (Appendix Fig. 2). 
Participants at the 75th percentile of the GBI distribution 
showed higher levels of Prevotella (22.25% v. 20%), 
Streptococcus (19.83% v. 17.61%), Porphyromonas (3.63% v. 
1.42%; P = 0.03), Treponema (1.02% v. 0.28%; P = 0.009), 
Parvimonas (0.28% v. 0.07%, P = 0.02) and Dialister (0.27% 
v. 0.10%, P = 0.04) as compared with participants in the lower 
GBI, who, comparatively, presented with higher levels of 
Veillonella (19.65% v. 12.94%, P = 0.02), Haemophilus 
(12.83% v. 8.48%, P = 0.05), Actinomyces (2.85% v. 1.90%) 
and Rothia (2.36% v. 1.55%) (Appendix Fig. 3). Patients with 
PMOL had higher proportions of Haemophilus (12.24% v. 
11.03%), Neisseria (6.67% v. 4.07%), Porphyromonas (2.37% 
v. 1.18%), Actinobacillus (1.65% v. 0.71%; P = 0.04), 
Selenomonas (0.96% v. 0.40%; P = 0.047), Capnocytophaga 
(0.66% × 0.28%; P = 0.009) and Treponema (0.59% v. 0.33%), 
as compared with those without PMOL (Appendix Fig. 4).
Microbial Profiles Associated with Potential  
Risk Factors for OSCC in FA
When high-risk (n = 51) participants were compared with the 
medium/low group (n = 10), limited differences were observed 
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Table. Participants’ Sociodemographic Characteristics (n = 61).
High Risk  
83.6%  (n = 51)
Moderate and Low Risk 
16.4%  (n = 10) P Value 100%  (n = 61)
Sociodemographic characteristicsa
Age, yb Median (range) 22 (11 to 44) 16 (11 to 40) 0.010***      100
Gender Male 47.5 (29) 9.8 (6) 0.57** 57.4 (35)
Female 36.1 (22) 6.6 (4) 42.6 (26)
Marital status Married 60.7 (37) 13.1 (8) 0.479** 73.8 (45)
Not married 23.0 (14) 3.3 (2) 26.2 (16)
Ethnicity White 41 (25) 8.2 (5) 0.955* 49.2 (30)
Not White 42.6 (26) 8.2 (5) 50.8 (31)
Level education Elementary school 37.7 (23) 11.5 (7) 0.38** 49.2 (30)
High school 36.1 (22) 3.3 (2) 39.3 (24)
Graduate 9.8 (6) 1.6 (1) 11.5 (7)
Profession Student 31.1 (19) 8.2 (5) 0.51** 39.3 (24)
Working 24.6 (15) 1.6 (1) 26.2 (16)
Not working 27.9 (17) 6.6 (4) 34.4 (21)
Family income monthly ≤$438.25 53.3 (32) 10 (6) 0.539** 63.3 (38)
>$438.25 30 (18) 6.7 (94) 36.7 (22)
Per-capita income monthlyb Median (range) $109.56  
($9.73 to $834.24)
$129.77  
($43.83 to $834.24)
0.758*** 98.3 (60)
Oral cancer risk factor
HSCT Yes 80.3 (49) 6.6 (4) 0.0001** 86.9 (53)
No 3.3 (2) 9.8 (6) 13.1 (8)
HSCT time Median (range) 11 (1 to 27) (n = 49) 3 (2 to 4) (n = 4) 0.003*** 100 (53)
Mucositis level Level I (Level 0 and 1) 28.6 (14) 2.4 (1) 0.99** 31 (15)
Level II (Level 2) 49.0 (24) 4 (2) 53 (26)
Level III (Level 3 and 4) 16 (8) 0 16 (8)
Systemic GVHD Yes 50.9 (27) 5.7 (3) 0.412** 56.6 (30)
No 41.5 (22) 1.9 (1) 43.4 (23)
Oral GVHD Yes 45.3 (24) 5.7 (3) 0.320** 50.9 (27)
No 47.2 (25) 1.9 (1) 49.1 (26)
PMOL Yes 60.7 (37) 1.6 (1) 0.0001** 62.3 (38)
No 23 (14) 14.8 (9) 37.7 (23)
Neutrophilsb Median (range) 3,024/mm3  
(460 to 7,560/mm3)
1,349/mm3 (593 to  
4,972/mm3)
0.017*** 100 (61)
Plateletsb Median (range) 217,000/mm3  
(66,000 to 468,000/mm3)
91,500/mm3 (24,000 to 
247,000/mm3)
0.002*** 100 (61)
Tobacco use Yes 1.6 (1) 0 0.646** 1.6 (1)
No 72.1 (44) 16.4 (10) 88.5 (54)
Former smoker 9.8 (6) 0 9.8 (6)
Alcohol consumption Yes 18 (11) 0 0.249** 18 (11)
No 62.3 (38) 16.4 (10) 78.7 (48)
Former drinker 3.3 (2) 0 3.3 (2)
Oral status
Gingival bleeding Yes 32.8 (20) 4.9 (3) 0.432** 37.3 (23)
No 50.8 (31) 11.5 (7) 62.3 (38)
When gingiva bleeds Tooth brushing 73.9 (17) 8.7 (2) 0.16** 82.6 (19)
Spontaneously 0 4.3 (1) 4.3 (1)
Other 13 (3) 0 13 (3)
Gum disease Yes 14.8 (9) 0 0.259** 14.8 (9)
No 60.7 (37) 16.4 (10) 77 (47)
I don’t know 8.2 (5) 0 8.2 (5)
Oral health reported Excellent, Very good or  
 Good
50.8 (31) 11.5 (7) 1.0** 62.3 (38)
Regular 27.9 (17) 4.9 (3) 32.8 (20)
Poor 4.9 (3) 0 4.9 (3)
Teeth became loose Yes 11.55 (7) 0 0.265** 11.55 (7)
No 72.1 (44) 16.4 (10) 88.5 (54)
Lost bone around teeth Yes 18 (11) 3.3 (2) 1.0** 21.3 (13)
No 62.3 (38) 13.1 (8) 75.4 (46)
I don’t know 3.3 (2) 0 3.3 (2)
DMFTb Median (range) 4 (0 to 25) 4 (0 to 11) 0.543*** 100 (61)
VPIb Median (range) 25 (0 to 100) 19.45 (2.8 to 47.20) 0.227*** 100 (61)
GBIb Median (range) 27.4 (0 to 100) 20.4 (3.80 to 50) 0.270*** 91.8 (56)
DMFT, decayed, missing, and filled teeth; GVHD, graft-versus host disease; GBI, gingival bleeding index; HSCT, hematopoietic stem cell transplantation; 
PMOL, potentially malignant oral lesions; VPI, visual plaque index.  
*Chi-square test; **Fisher exact test; ***Mann–Whitney U test; P values in bold are P < 0.05.
aData are presented as % (n), unless otherwise indicated.
bMedian (all participants) values for: Age, 21 y (range, 11 to 44 y); Per-capita Income Monthly, $113.14 ($9.73 to $834.24); Neutrophils, 3,134/mm3 
(460 to 7,560); Platelets, 21,700/mm3 (24,000 to 468,00); DMFT, 4 (0 to 25); VPI, 25% (0 to 100); GBI, 26.9% (0 to 100).
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(Appendix Fig. 5). When risk factors were analyzed individually, 
history of oral GVHD (n = 27) was associated with higher pro-
portions of Firmicutes (43.8% v. 38.5%; P = 0.05). Levels of 
Veillonella (20.2% v. 15.7%), Streptococcus (18.7% v. 16%) and 
Haemophilus (13.0% v. 10.7%) were also higher in this group as 
compared with participants who did not have oral GVHD (Fig. 
1).
Regarding history of oral mucositis, more severe cases (III: 
Levels 3 and 4) harbored higher levels of Streptococcus 
(19.25%), Haemophilus (12.8%), Aggregatibacter (3.6%, P = 
0.009), as well as Selenomonas (1.9%, P = 
0.007), Capnocytophaga (1.02%, P = 0.02) 
and Corynebacterium (0.5%, P = 0.01) as 
compared with the less severe groups (Fig. 2).
The time since HSCT was stratified into 4 
levels: 0 to 2 y, 3 to 5 y, 6 to 10 y and 11 y and 
over. First, we assessed HSCT using princi-
pal coordinate analysis based on unweighted 
Unifrac distances (Fig. 3). This analysis sug-
gested a tendency for there to be data parti-
tioning, as samples from participants who 
had HSCT in recent years appeared to cluster 
together and away from the samples pro-
vided by participants who had HSCT in ear-
lier years. The genus-level analysis of the data 
indicated that the group whose time since 
HSCT was 11 y or more had the highest lev-
els of Streptococcus (18.4%), Haemophilus 
(12.7%) and Neisseria (6.8%) as compared 
with other groups (Fig. 4).
Discussion
Susceptibility to OSCC is not fully explained 
in FA or in the general population. Due in 
part to their young age and awareness of their 
cancer susceptibility, FA patients do not typi-
cally smoke or consume alcohol. Within the 
general population, even among smokers and 
drinkers, only a small proportion of individu-
als develop OSCC. Therefore, other environ-
mental factors may synergize with those 
exposures. Thus, this study aimed to explore 
the microbial salivary profiles of FA patients 
about OSCC risk factors. The inherent 
genomic instability of FA patients may coop-
erate with other environmental exposures 
(such as the local microbiome) aside from 
the classical risk factors, and this would add 
to the multitude of elements that can collec-
tively promote carcinogenesis.
Infection and inflammation are important 
mediators of cancer development, particu-
larly for OSCC (Meurman and Bascones-
Martinez 2011). The mouth is heavily 
colonized by bacteria (Dewhirst et al. 2010), 
and exposure stemming from the microbi-
ome, induced local inflammation, or metabolites produced by 
the host or microbiota, may contribute to OSCC development. 
Several oral species have been associated with OSSC (Mager 
et al. 2005) and a link between plaque-induced periodontal dis-
eases and oral cancer has been proposed (Meurman and 
Bascones-Martinez 2011).
In the present study, Firmicutes and Bacteriodetes were the 
most common phyla, which is in accord with studies of the oral 
microbiome in health and disease (Guerrero-Preston et al. 
2016). In addition, Prevotella, Veillonella, and Streptococcus 
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Figure 1. Mean relative abundance of the most prevalent genera in saliva samples from 
patients with (red, n = 27) and without (blue, n = 26) a history of oral graft-versus-host disease 
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Figure 2. Mean relative abundance of the most prevalent genera detected in saliva samples 
according to the level of mucositis. Blue: Patients with mucositis levels 0 and 1 (n = 15); orange: 
patients with mucositis level 2 (n = 26); red: patients with mucositis level 3 and 4 (n = 8). Only 
one patient presented with a mucositis level of 0, and one patient presented with a mucositis 
level of 4. When a genus-level resolution could not be achieved, the next taxonomic level was 
presented. p, phylum; c, class; o, order; f, family. *P < 0.05 (Differences did not reach false 
discovery rate [FDR] adjusted statistical significance).
Salivary Microbiome and Oral Cancer Risk  297
were the most frequently detected genera, which is in line with 
the literature (Al-Hebshi et al. 2015; Guerrero-Preston et al. 
2016). FA patients showed VPI (31.3%) and GBI (34.2%) lev-
els that are higher than the recommended levels. However, FA 
patients do not present inherently poorer oral health. Lyko et al. 
(2016) found no differences in DMFT and oral hygiene index 
between FA individuals and a paired control group. Our DMFT 
results were in line with the findings of Yalman et al. (2001), 
who reported a mean DMFT of 5 in transplanted FA patients. 
Using culture, the authors compared the microbiota and DMFT 
of HSCT and non-HSCT FA patients, and found no differences 
in the levels of Lactobacilli and Streptococcus mutans. In the 
present study, we found a trend for increased levels of 
Streptococcus ssp. in participants with DMFT equal to or above 
8. Among the oral parameters examined, we focused on GBI 
because of its association with inflammatory responses to the 
local microbial insult and because it is a more objective metric 
than VPI. Participants with a higher GBI (Appendix Fig. 3) 
showed elevated levels of Porphyromonas, Treponema, 
Prevotella, Parvimonas and Dialister spp. Interestingly, those 
genera include members of the red (Porphyromonas gingivalis, 
Treponema denticola) and orange (Prevotella intermedia and 
Parvimonas micra) complexes (Socransky and Haffajee 2005) 
as well as newly proposed periodontal pathogens (Dialister 
pneumosintes and Dialister invisus) (Pérez-Chaparro et al. 
2014), all of which are associated with the inflammation of 
periodontal tissues (Socransky and Haffajee 2005). Only one 
previous study investigated the presence of periodontal patho-
gens (Aggregatibacter actinomycetemcomitans, Porphyromonas 
gingivalis, Fusobacterium nucleatum, and Treponema dentic-
ola) in the oral cavity of subjects with FA and found no differ-
ences in their levels as compared with matched controls (Lyko 
et al. 2013).
Based on the literature and our clinical experience, we pro-
pose a set of risk factors and categories. When comparing 
microbial profiles, we found a recurring theme in terms of the 
elevated presence of Streptococcus, Neisseria, Veillonella and 
Haemophilus concomitant with oral GVHD (Streptococcus, 
Veillonella, Haemophilus; Fig. 1), severe mucositis (Streptococcus, 
Haemophilus; Fig. 2), longer time since HSCT (Streptococcus, 
Neisseria, Haemophilus; Fig. 4), PMOL (Neisseria, 
Haemophilus; Supplemental Fig. 4) and high risk (i.e., patients 
that received HSCT more than 5 years prior to the present 
examination or subjects ≥18 years old presenting an oral 
lesion) (Neisseria, Haemophilus; Appendix Fig. 5). Our results 
are in accord with recently reported associations between these 
taxa and cancer. Guerrero-Preston et al. (2016) demonstrated 
that Streptococcus Haemophilus and Veillonella were the most 
abundant taxa in the saliva of OSCC patients, and Pustelny et al. 
(2015) showed that Veillonella parvula preferentially colo-
nizes neoplastic tissues. Higher proportions of Haemophilus 
and Neisseria have been detected in patients with oral leuko-
plakia (Hu et al. 2016) and oral erosive lichen planus (Wang 
et al. 2016), respectively. Further, Al-Hebshi et al. (2015) 
found that Neisseria, Haemophilus and Streptococcus were 
among the most abundant genera in OSCC. Also, Neisseria 
accounted for 8%, 4%, and 5% of the microbiota of laryngeal 
squamous cell carcinoma, adjacent normal tissue and control 
tissues, respectively (Gong et al. 2013). Finally, esophageal 
precancerous lesions are enriched for Neisseria and Veillonella 
(Pilato et al. 2016).
The relevance of our findings is further supported by an 
earlier study that reported high salivary levels of Streptococcus 
mitis in patients with OSCC (Mager et al. 2005), and recent 
investigations showing that Streptococcus spp. (including S. 
mitis) and Neisseria can synthesize acetaldehyde (Moritani et al. 
2015), a well-known carcinogen. Indeed, the oral microbiota 
seems to be a major determinant of salivary acetaldehyde lev-
els (Marttila et al. 2013),  which can be decreased using an 
antimicrobial rinse (Homann et al. 1997). Moreover, the syner-
gism between conventional risks factors and microorganisms 
via aldehyde production has been described for esophageal 
cancer (Peng et al. 2016). Although a few studies have found 
similar levels of Streptococcus and Neisseria (Hu et al. 2016) 
in healthy subjects and OSCC patients, we hypothesize that 
their levels are a bigger challenge for FA patients, considering 
their deficiency in DNA repair mechanisms.
Our results are particularly relevant for the FA population 
because of the toxicity of aldehydes noted in these patients 
(Garaycoechea et al. 2012). Indeed, higher aldehyde concentra-
tions seem to interact directly with lipid peroxidation of the cell 
and induce DNA damage (Garcia et al. 2011). Ethanol exposure 
can also lead to acetaldehyde accumulation, causing bone mar-
row dysfunction in FA patients (Ghosh et al. 2014). We found 
that some participants classified as a high risk in our study were 
current or former smokers (n = 11) or alcohol drinkers (n = 13), 
and these insults might have influenced the profiles of these 
patients. Further, both habits enhance acetaldehyde production 
by the oral microbiome (Marttila et al. 2013). 
There are limitations in the present study. The first is its sample 
size. However, because FA is estimated to occur in 1:250,000 
births (Dong et al. 2015), the present study population is of a 
Figure 3. Principal Coordinate Analysis (based on unweighted Unifrac 
distances) according to time in years since HSCT. Increasingly darker 
shades of orange and red refer to increasing years increase HSCT. The 
number of participants in each time category is indicated in parenthesis. 
Only participants who received HSCT were plotted.
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representative size for an FA study. Still, the smaller sample size 
presents many challenges, as conventional sample size calculations 
are difficult to achieve, and the heterogeneity of the group hampers 
the utilization of strict inclusion and exclusion criteria. A second 
limitation of the present study is its cross-sectional design, which 
precludes any inference on a causal role of the oral microbiome in 
OSCC susceptibility. However, despite these considerations, our 
results represent a significant first step in understanding the FA oral 
microbiome and its potential contribution to OSCC development 
in FA and, possibly, in the general population.
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